Sangeeta Bhatia

Sangeeta Bhatia is an American bioengineer and physician whose pioneering work bridges nanotechnology, tissue engineering, and disease biology. A professor at the Massachusetts Institute of Technology and a member of the Koch Institute for Integrative Cancer Research, she is renowned for developing human microlivers for drug testing and creating novel nanoparticle-based technologies for cancer diagnosis and therapy. Her interdisciplinary research has earned her election to all three branches of the United States National Academies.

Early life and education

Sangeeta Bhatia was born to immigrant parents from India and grew up in Boston, showing an early aptitude for mathematics and science. She completed her undergraduate studies in biomedical engineering at Brown University, graduating with honors. Bhatia then pursued a dual degree program, earning a Master of Science in mechanical engineering and a Doctor of Philosophy in bioengineering from the Massachusetts Institute of Technology, where her doctoral research on liver tissue engineering was advised by the renowned physicist Mildred Dresselhaus. Concurrently, she obtained her Doctor of Medicine from Harvard Medical School through the Harvard–MIT Program in Health Sciences and Technology, completing her clinical training in internal medicine at the Brigham and Women's Hospital.

Research and career

Bhatia's research career is distinguished by its integration of microfabrication tools from the semiconductor industry with principles of cell biology and medicine. Her early groundbreaking work involved creating the first microfabricated liver tissue, a platform of hepatocytes patterned using techniques from computer chip manufacturing. This innovation led to the development of scalable human microlivers that are used globally by pharmaceutical companies like Pfizer and Novartis to model liver disease and test drug metabolism, reducing reliance on animal testing. At the Koch Institute for Integrative Cancer Research and the Institute for Medical Engineering and Science, her lab has pioneered nanotechnology-based strategies for cancer, including synthetic biomarkers that detect tumors through simple urine tests and targeted nanoparticles for delivering therapeutics and imaging agents. She has co-founded several biotechnology companies, including Glympse Bio and Satellite Bio, to translate these discoveries. Bhatia also serves as a director for Vertex Pharmaceuticals and has held leadership roles in scientific organizations like the American Institute for Medical and Biological Engineering.

Awards and honors

Sangeeta Bhatia has received widespread recognition for her contributions to science and engineering. She is one of the few individuals elected to all three United States National Academies: the National Academy of Engineering, the National Academy of Sciences, and the National Academy of Medicine. Her major awards include the prestigious Lemelson–MIT Prize, often called the "Oscar for inventors," and the Heinz Award for Technology, the Economy and Employment. She is also a recipient of the Othmer Gold Medal, the MIT School of Engineering's C. H. Hood Award, and a fellowship from the John D. and Catherine T. MacArthur Foundation. Bhatia has been honored by the American Association for the Advancement of Science and is a fellow of the American Institute for Medical and Biological Engineering and the Biomedical Engineering Society.

Selected publications

Bhatia's influential research is documented in numerous high-impact journal articles and patents. Key publications include seminal papers in *Nature Biotechnology* on micropatterned co-cultures of hepatocytes, work in *Science* detailing protease-activated nanoparticles for cancer detection, and studies in *Nature Materials* on nanosensors for non-invasive monitoring of liver fibrosis. Her team's report in *Proceedings of the National Academy of Sciences* on synthetic biomarkers for early cancer diagnosis and a review in *Annual Review of Biomedical Engineering* on engineering the hepatic microenvironment are also widely cited. These publications have shaped the fields of tissue engineering and nanomedicine.

Personal life

Sangeeta Bhatia is married to Jagesh Shah, a systems biologist and professor at Harvard Medical School. They have two children and reside in Cambridge, Massachusetts. An advocate for STEM education and diversity in science, she actively mentors students and has participated in initiatives like the White House's United States Science Envoy program. Outside the laboratory, she enjoys spending time with her family and has spoken about the challenges and rewards of balancing a high-powered research career with family life.

Category:American bioengineers Category:American women engineers Category:Living people Category:Massachusetts Institute of Technology faculty